Skip to main content

2030年までに主要地域の驚異的な成長を設定する英国のIVD市場

 


UK IVD market accounted for $2.1 billion in 2016, and is estimated to reach $3.1 billion by 2023, growing at a CAGR of 5.4% during the analysis period (2017-2023).

In-vitro diagnostics (IVD) is the technique in which medical devices and reagents are utilized to analyze biological samples such as blood, urine, stool, tissues, and other body fluids, derived from the human body to detect diseases and infections. In addition, the tests are performed in stand-alone laboratory, and hospital-based laboratory. Some of the significant technologies incorporated in in vitro diagnostics include polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/3602

Based on product type, the reagents segment held the highest market share in 2016, owing to the recent introduction of new reagents R&D in the filed for chemical science.

Based on technique, the immunodiagnostics segment contributed the highest market share in 2016, owing to the increase in prevalence of chronic diseases and rise in demand for minimally invasive technique.

Based on application, the infectious diseases segment contributed the highest market share in 2016, due to high rate of the incidences of infectious diseases and rise in awareness of preventive health measures.

Based on end users, the standalone laboratory segment captured the highest market share in 2016, mainly due to wide availability of complex tests and high-tech infrastructure enabling fast and accurate test results.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/3602

The Major Key Players Are:

·        Thermo Fisher Scientific Inc.

·        Alere Inc.

·        Biomerieux, Danaher Corporation

·        F. Hoffmann-La Roche AG

·        Becton Dickinson and Company

·        Bio-Rad Laboratories

·        Bayer AG

·        Sysmex Corporation

·        Johnson & Johnson.

Key Findings of the UK IVD Market:

  • The immunodiagnostics segment dominated the market in 2016, and is projected to grow at the 5.6% CAGR.
  • The immunodiagnostics segment accounted for the highest share in 2016.
  • The pathology segment was the major shareholder in the UK IVD based application market in 2016.
  • The standalone laboratory segment accounted for the highest share in 2016.
  • UK is expected to grow at the highest CAGR in the IVD market.

Access Full Report @ https://www.alliedmarketresearch.com/uk-ivd-market

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: 
https://www.alliedmarketresearch.com

Comments

Popular posts from this blog

電子健康記録(EHR)市場 ガーナーへ $33.29 Bn, グローバルに, で 5.0% CAGR

T he global   Electronic Health Records (EHR) Market   generated $24.90 billion in 2017, and is expected to generate $33.29 billion by 2023, registering a CAGR of 5.0% from 2017 to 2023. The report offers a detailed analysis of drivers & opportunities, market size & estimations, top winning strategies, key segments, and competitive scenario. Increase in acceptance of cloud-based EHR software worldwide, surge in incidence of chronic diseases, and rise in ageing population drive the growth of the global EHR market. However, expensive EHR software and rise in concerns regarding data security & safety hinder the growth of the industry. On the other hand, untapped potential in emerging countries create lucrative opportunities in the future. Download Sample Report at:   https://www.alliedmarketresearch.com/request-sample/4542 Based on product, the cloud-based software segment is expected to register the highest CAGR of 5.3% from 2017 to 2023, owing to the less upfront costs and l

ライフサイエンス試薬市場、トレンド、分析、機会、シェア、2019-2027年までの予測

  " Life Science Reagents Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in the report." Life Science Reagents Market Research has offered exhaustive analysis of Manufacturers, Suppliers, Regions, Type and Application, Forecast to 2027. And also provides essential study on the current status of the market, cover market size with respect to valuation as sales volume and providing a precise prediction of the market scenario over the forecast period from 2020 to 2027. Download Free Sample PDF@   https://www.alliedmarketresearch.com/request-sample/12658 The report provides revenue forecast with sales, sales growth rate, and revenue growth rate forecasts of the global    Life S

副鼻腔拡張デバイス市場 Expected to Reach $5,778 Million by 2023 - Allied Market Research

  Sinus Dilation Devices Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023 ," the global sinus dilation devices market was valued at   $3,326 million   in 2016, and is projected to reach   $5,778 million   at a CAGR of 8.1% from 2017 to 2023. Sinusitis is a medical condition wherein inflammation of sinus lining leads to a plugged nose, headache, poor sense of smell, sore throat, and cough. It is caused due to either ostial blockage, bacterial infections, viral infections, or a combination of these conditions. This leads to use of sinus dilation devices during surgical procedures to dilate the sinus openings of a patient's nose. Request for Sample Report at:   https://www.alliedmarketresearch.com/request-sample/2128 The major factors that drive the global sinus dilation devices market are increase in incidence of sinusitis, which may lead to higher sinus surgeries, high adoption of minimally invasive surgical procedures, and technologi